Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
2011

Role of Urokinase Receptor in Chondrosarcoma Cell Movement

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Katia Bifulco, Immacolata Longanesi-Cattani, Maria Teresa Masucci, Annarosaria De Chiara, Flavio Fazioli, Gioconda Di Carluccio, Giuseppe Pirozzi, Michele Gallo, Antonello La Rocca, Gaetano Apice, Gaetano Rocco, Maria Vincenza Carriero

Primary Institution: National Cancer Institute of Naples

Hypothesis

High levels of soluble urokinase receptor (SuPAR) in chondrosarcoma may promote cell migration and invasion.

Conclusion

The study found that SuPAR promotes chondrosarcoma cell migration and invasion, suggesting its potential as a therapeutic target.

Supporting Evidence

  • High levels of uPAR and SuPAR correlate with poor prognosis in chondrosarcoma patients.
  • Chondrosarcoma cells release a large amount of SuPAR into the medium.
  • In vitro assays showed that SuPAR enhances cell migration and invasion.

Takeaway

Chondrosarcoma cells can move and invade tissues better when they have more SuPAR, which is a protein that helps them do this.

Methodology

The study involved analyzing uPAR levels in tissues and plasma from patients, creating primary cell cultures, and conducting migration and invasion assays.

Limitations

The study had a small sample size and focused only on in vitro experiments.

Participant Demographics

Patients aged 34 to 72 years, with varying grades of chondrosarcoma.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/842842

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication